Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ABRAHAM S SALACATA

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1255440095
CMS profile
101995
Location
ALPENA, MI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$347.73

18 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $347.73 18

By paying entity

PY2024 · entire year · sorted by reported total

Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ABRAHAM S SALACATA

NPI 1255440095 · CMS profile ID 101995

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

ALPENA, MI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1255440095?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ABRAHAM S SALACATA, NPI 1255440095, CMS profile ID 101995. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1255440095?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). ABRAHAM S SALACATA, NPI 1255440095, CMS profile ID 101995. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1255440095?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
ABRAHAM S SALACATA, NPI 1255440095, CMS profile ID 101995, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1255440095?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

18 matching records · $347.73 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 18 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–18 of 18.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $13.5709/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101829242 CMS
Actelion Pharmaceuticals US, Inc. $18.0806/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078892863 CMS
Actelion Pharmaceuticals US, Inc. $14.6706/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078892865 CMS
AstraZeneca Pharmaceuticals LP $17.1106/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105553238 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.2706/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117935461 CMS
Cook Medical LLC $14.5806/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117467728 CMS
Abbott Laboratories $21.0306/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124925795 CMS
Actelion Pharmaceuticals US, Inc. $17.6305/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078892871 CMS
Kestra Medical Technology Services, Inc. $25.5605/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152376279 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $14.6803/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1080554317 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.8503/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117935459 CMS
SCPHARMACEUTICALS INC. $13.9903/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132259276 CMS
E.R. Squibb & Sons, L.L.C. $16.8202/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101829224 CMS
ABIOMED $37.5002/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142264379 CMS
Actelion Pharmaceuticals US, Inc. $15.6602/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078892869 CMS
Kiniksa Pharmaceuticals International, plc $14.7802/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154879230 CMS
Actelion Pharmaceuticals US, Inc. $15.7201/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078892867 CMS
AstraZeneca Pharmaceuticals LP $32.2301/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104629046 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,254.35 23
PY2020 $1,854.77 27
PY2021 $993.92 38
PY2022 $880.13 46
PY2023 $854.49 36
PY2024 $347.73 18
PY2025 $2,156.96 21

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $34,407.43 44
PY2020 Principal investigator $48,633.68 82
PY2019 Principal investigator $95,505.89 140

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

44 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 12/13/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336481
Principal investigator 1 Boehringer Ingelheim International GmbH $796.00 12/13/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336483
Principal investigator 1 Boehringer Ingelheim International GmbH $831.00 12/13/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336485
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 12/13/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336511
Principal investigator 1 Boehringer Ingelheim International GmbH $796.00 12/13/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336517
Principal investigator 1 Boehringer Ingelheim International GmbH $796.00 12/13/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336519
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 12/13/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336521
Principal investigator 1 Boehringer Ingelheim International GmbH $7,036.90 10/01/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336515
Principal investigator 1 Boehringer Ingelheim International GmbH $250.10 09/17/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336493
Principal investigator 1 Boehringer Ingelheim International GmbH $831.00 09/17/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336495
Principal investigator 1 Boehringer Ingelheim International GmbH $858.00 09/17/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336497
Principal investigator 1 Boehringer Ingelheim International GmbH $956.00 09/17/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336499
Principal investigator 1 Boehringer Ingelheim International GmbH $0.86 08/06/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336487
Principal investigator 1 Boehringer Ingelheim International GmbH $1.73 08/06/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336489
Principal investigator 1 Boehringer Ingelheim International GmbH $8.64 08/06/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336491
Principal investigator 1 Boehringer Ingelheim International GmbH $0.86 08/06/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336501
Principal investigator 1 Boehringer Ingelheim International GmbH $0.86 08/06/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336503
Principal investigator 1 Boehringer Ingelheim International GmbH $1.73 08/06/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336505
Principal investigator 1 Boehringer Ingelheim International GmbH $1.73 08/06/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336507
Principal investigator 1 Boehringer Ingelheim International GmbH $1.73 08/06/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336509
Principal investigator 1 Boehringer Ingelheim International GmbH $1.73 08/06/2021 Non-covered Recipient Entity
ALPENA GENERAL HOSPITAL
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828336513
Principal investigator 1 Boehringer Ingelheim International GmbH $7,069.00 04/14/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337309
Principal investigator 1 Boehringer Ingelheim International GmbH $842.00 04/14/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337311
Principal investigator 1 Boehringer Ingelheim International GmbH $504.00 04/14/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337313
Principal investigator 1 Boehringer Ingelheim International GmbH $693.00 04/07/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337305
Principal investigator 1 Boehringer Ingelheim International GmbH $693.00 04/07/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337307
Principal investigator 1 Boehringer Ingelheim International GmbH $693.00 04/07/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337315
Principal investigator 1 Boehringer Ingelheim International GmbH $693.00 04/07/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337317
Principal investigator 1 Boehringer Ingelheim International GmbH $693.00 04/07/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337319
Principal investigator 1 Boehringer Ingelheim International GmbH $693.00 04/07/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337321
Principal investigator 1 Boehringer Ingelheim International GmbH $956.00 03/08/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337301
Principal investigator 1 Boehringer Ingelheim International GmbH $956.00 03/08/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337303
Principal investigator 1 Boehringer Ingelheim International GmbH $956.00 03/08/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337335
Principal investigator 1 Boehringer Ingelheim International GmbH $956.00 03/08/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337337
Principal investigator 1 Boehringer Ingelheim International GmbH $956.00 03/08/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337339
Principal investigator 1 Boehringer Ingelheim International GmbH $956.00 03/08/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337341
Principal investigator 1 Boehringer Ingelheim International GmbH $10.88 03/03/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337323
Principal investigator 1 Boehringer Ingelheim International GmbH $196.68 03/03/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337325
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 02/05/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337327
Principal investigator 1 Boehringer Ingelheim International GmbH $81.00 02/05/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337329
Principal investigator 1 Amgen Inc. $1,325.00 01/22/2021 Non-covered Recipient Entity
ENDEAVOR MEDICAL RESEARCH
(GOULD): a Registry of High Cardiovascular Risk Subjects in the United States No dispute reported 06/30/2026 830982577
Principal investigator 1 Boehringer Ingelheim International GmbH $831.00 01/15/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337343
Principal investigator 1 Boehringer Ingelheim International GmbH $79.50 01/05/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337331
Principal investigator 1 Boehringer Ingelheim International GmbH $79.50 01/05/2021 Non-covered Recipient Entity
ENDEAVOR MEDCL RSRCH
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828337333